Penn Davis McFarland’s Natus Medical Inc NTUS Stock Holding History

Penn Davis McFarland’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-6,500	Closed	-$232K	–	43
2018 Q3	$232K	Hold	6,500	–	–	0.07%	40
2018 Q2	$224K	Buy	+6,500	New	+$228K	0.07%	41

Other funds holding NTUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Penn Davis McFarland's NTUS Position: Q4 2018 in Review

Penn Davis McFarland sold out of Natus Medical Inc (NTUS) in Q4 2018, closing a stake of 6,500 shares — an estimated $232K sold.

Penn Davis McFarland first reported a position in NTUS in Q2 2018 and held it in 2 quarters. The position peaked at $232K in Q3 2018. 174 funds tracked by Wall St. Rank hold NTUS as of Q4 2018.

Penn Davis McFarland reported no remaining Natus Medical Inc position as of Q4 2018 after selling out during the quarter.
Penn Davis McFarland sold 6,500 Natus Medical Inc shares in Q4 2018, an estimated $232K.
Penn Davis McFarland first reported a position in Natus Medical Inc in Q2 2018 and held it in 2 quarters.
Penn Davis McFarland's Natus Medical Inc position peaked at $232K in Q3 2018.
174 funds tracked by Wall St. Rank held Natus Medical Inc as of Q4 2018.

Based on Penn Davis McFarland's 13F filing for Q4 2018, filed 18 Jan 2019.